A 2020 study highlighted that elevated Fet-A levels could predict a better response to rituximab treatment in RA patients who had previously failed anti-TNFα therapy, suggesting a potential role for Fet-A in therapeutic stratification [168]. The gene discussed is TNF; the disease is rheumatoid arthritis.